Atherogenic Lipoprotein Particles in Atherosclerosis

DOI Web Site 被引用文献12件
  • Rafael Carmena
    From the Department of Endocrinology and Nutrition (R.C.), Facultad de Medicina y Hospital Clínico Universitario, Valencia, Spain; Faculté de Pharmacie (P.D., J.-C.F.), Université du Droit et de la Santé de Lille 2, and the Département de Recherche sur les Lipoprotéines et l’Athérosclérose, Inserm U545 (P.D., J.-C.F.), Institut Pasteur de Lille, Lille, France.
  • Patrick Duriez
    From the Department of Endocrinology and Nutrition (R.C.), Facultad de Medicina y Hospital Clínico Universitario, Valencia, Spain; Faculté de Pharmacie (P.D., J.-C.F.), Université du Droit et de la Santé de Lille 2, and the Département de Recherche sur les Lipoprotéines et l’Athérosclérose, Inserm U545 (P.D., J.-C.F.), Institut Pasteur de Lille, Lille, France.
  • Jean-Charles Fruchart
    From the Department of Endocrinology and Nutrition (R.C.), Facultad de Medicina y Hospital Clínico Universitario, Valencia, Spain; Faculté de Pharmacie (P.D., J.-C.F.), Université du Droit et de la Santé de Lille 2, and the Département de Recherche sur les Lipoprotéines et l’Athérosclérose, Inserm U545 (P.D., J.-C.F.), Institut Pasteur de Lille, Lille, France.

抄録

<jats:p>The importance of low-density lipoprotein (LDL) cholesterol in the development of atherosclerosis has long been recognized, and LDL cholesterol remains the primary target of therapy for the prevention of coronary heart disease. Nevertheless, increasing research attention over the past decade has been devoted to the heterogeneity of LDL particles and the atherogenicity of lipids and lipoproteins other than LDL. Particularly atherogenic forms of LDL include small, dense LDL particles and oxidized LDL. All lipoproteins that contain apolipoprotein B, such as LDL, very-low-density lipoprotein, and intermediate-density lipoprotein, tend to promote atherosclerosis; however, these particles differ in their apolipoprotein and triglyceride content. High levels of plasma triglycerides increase the risk of acute coronary events. Lipoprotein(a) is now considered an independent risk factor in both men and women. Ultimately, better understanding of the roles of these lipid particles and subfractions in the initiation and progression of atherosclerosis may affect treatment decisions.</jats:p>

収録刊行物

  • Circulation

    Circulation 109 (23_suppl_1), III2-, 2004-06-15

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (12)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ